FDA's Has Big Plans to Get Drugs Approved Faster, Tackle Drug Development Costs Post author:Sam Post published:September 11, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Horizon Pharma Pays $145 Million For And Its Rare Eye Disease Drug May 7, 2017 Job Cuts and Facility Reductions Loom Over SoCal's ImmunoCellular August 23, 2017 FDA Approves Genentech's Zelboraf, the First-Ever Drug to Treat Specific Rare Blood Disease November 6, 2017
FDA Approves Genentech's Zelboraf, the First-Ever Drug to Treat Specific Rare Blood Disease November 6, 2017